Xenon Pharmaceuticals (XENE) Invested Capital (2017 - 2020)
Xenon Pharmaceuticals (XENE) posted quarterly Invested Capital of $15.5 million for Q1 2020, little changed year-over-year from $15.5 million in Q2 2019, and little changed quarter-over-quarter from $15.5 million in Q4 2019.
Xenon Pharmaceuticals (XENE) Invested Capital (2017 - 2020) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Invested Capital for 4 consecutive years, with $15.5 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Invested Capital changed 0.0% year-over-year to $15.5 million; the TTM figure through Dec 2020 stood at $15.5 million (down 75.0% YoY), while the FY2019 annual figure was $15.5 million, changed 0.0% from the prior year.
- Invested Capital was little changed at $15.5 million in Q1 2020 per XENE's latest filing, from $15.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $15.5 million in Q4 2018 and bottomed at $1.4 million in Q1 2018.
- Historically, Invested Capital has averaged $11.8 million across 4 years, with a median of $15.5 million in 2018.
- On a YoY basis, Invested Capital climbed as much as 1007.14% in 2019 and fell as far as 0.0% in 2019.
- Xenon Pharmaceuticals' Invested Capital stood at $7.0 million in 2017, then surged by 121.43% to $15.5 million in 2018, then changed by 0.0% to $15.5 million in 2019, then changed by 0.0% to $15.5 million in 2020.
- Business Quant data shows XENE's Invested Capital at $15.5 million in Q1 2020, $15.5 million in Q4 2019, and $15.5 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 15.50 Mn |
| Dec 31, 2019 | 15.50 Mn |
| Sep 30, 2019 | 15.50 Mn |
| Jun 30, 2019 | 15.50 Mn |
| Mar 31, 2019 | 15.50 Mn |
| Dec 31, 2018 | 15.50 Mn |
| Jun 30, 2018 | 5.00 Mn |
| Mar 31, 2018 | 1.40 Mn |
| Dec 31, 2017 | 7.00 Mn |